Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125223
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-10-31
Brief Title:
PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Organization Data
Organization:
Xijing Hospital
Class:
OTHER
Study ID:
KY20232325
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xijing Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Shi LiMD
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Xijing Hospital
Old Name:
None
Old Organization:
None